发明授权
US06399640B1 Arylthiazolidinedione and aryloxazolidinedione derivatives 失效
芳基噻唑烷二酮和芳基恶唑烷二酮衍生物

Arylthiazolidinedione and aryloxazolidinedione derivatives
摘要:
Substituted 5-aryl-2,4-thiazolidinediones or 5-aryl-2,4-oxazolidinediones that also carry a second substituent in the 5-position of the heterocyclic ring are potent agonists of PPAR, and are therefore useful in the treatment, control or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and other PPAR &agr;, &dgr; and/or &ggr; mediated diseases, disorders and conditions.
信息查询
0/0